Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
In Phase 2 trials, retatrutide was administered as a once-weekly subcutaneous injection using a gradual dose escalation schedule to minimise gastrointestinal side effects
People start losing weight after about 4 weeks, with noticeable weight loss after several months, and with steady progress for up to 15 months
Significant prior efforts across the pharmaceutical industry have failed to identify potent and efficacious small-molecule agonists of the GLP-1R ( 15, 16 )
At least 27 new GLP-1 drugs are currently undergoing trials at various stages, including a triple-hormone-receptor agonist combining GLP-1, GIP and glucagon receptors
Combining Semaglutide with 150 minutes of exercise a week can yield even better results
US$ 23.54
US$ 25.23
US$ 25.73
US$ 26.55
US$ 24.73
US$ 20.38
US$ 23.05
US$ 29.45
US$ 21.80
US$ 21.51
US$ 22.20
